Shinobu Akuzawa

Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.

Akira Miyake, Shinobu Mochizuki, Yasuhiko Takemoto et al. · Molecular Pharmacology · 1995 · 184 citations

Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.

Akito Nishida, K Miyata, Rie Tsutsumi et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 88 citations · Full text

GABA-B Agonist Baclofen Normalizes Auditory-Evoked Neural Oscillations and Behavioral Deficits in the<i>Fmr1</i>Knockout Mouse Model of Fragile X Syndrome

Duncan Sinclair, Robert E. Featherstone, Melissa J. Naschek et al. · eNeuro · 2017 · 87 citations · Full text

(3<i>R</i>)-<i>N</i>-(1-(<i>tert</i>-Butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1<i>H</i>- 1,4-benzodiazepin-3-yl)-<i>N</i>‘-(3-(methylamino)phenyl)urea (YF476):  A Potent and Orally Active Gastrin/CCK-B Antagonist

Graeme Semple, Hamish Ryder, David P. Rooker et al. · Journal of Medicinal Chemistry · 1997 · 73 citations · Full text

Rat Pancreas, Gastrointestinal Pharmacology, Gastroenterology +17

YF476 is a new potent and selective gastrin/cholecystokinin‐B receptor antagonist <i>in vitro</i> and <i>in vivo</i>

Yusuke Takinami, Hidenobu Yuki, Akito Nishida et al. · Alimentary Pharmacology & Therapeutics · 1997 · 64 citations